thiopurine,adalimumab
abbvie,MAIA Biotech
['adalimumab', 'strident', 'thio']
prof m kamm: 2 year results of strident trial for cd strictures adalimumab mono vs high dose ada with thiopurine primary endpoint of obstructive score at 12 months not met (both arms improved!) improved mre score surgery rates at 2 yrs the same #ddw2023 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.